Keywords: metformin, gr, meets, goal, ph, iii, trial

Metformin GR meets goal in Ph III trial

Article | 22 December 2003

Preliminary findings from a Phase III trial of Canada-based Bioavail andUS partner Depomed's Metformin GR, a once-daily extended-release formulation of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bristol-Myers Squibb

Go to company listing

Related Drugs

Glyburide

Micronase

Nystatin

Go to drug listing